QSant™ is the first and only urine-based test for the detection of kidney transplant rejection.
QSant™ Clinical Validation Papers
Nephrosant has robust studies from over 1000 patient samples
Clinical validation of a non-invasive, spot urine-based transplant rejection test that provides risk of rejection up to 8 months before a rejection episode
Published: 18 March 2020
Development, validation, and clinical utility of a urinary Q-Score™ for the detection of acute rejection in adult and pediatric renal transplant patients
Published: 22 July 2020